| Pharmaceutical Information |
| Drug Name |
Nicardipine |
| Drug ID |
BADD_D01560 |
| Description |
A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents. [PubChem] |
| Indications and Usage |
Used for the management of patients with chronic stable angina and for the treatment of hypertension. |
| Marketing Status |
approved; investigational |
| ATC Code |
C08CA04 |
| DrugBank ID |
DB00622
|
| KEGG ID |
D08270
|
| MeSH ID |
D009529
|
| PubChem ID |
4474
|
| TTD Drug ID |
D0T0KA
|
| NDC Product Code |
Not Available |
| UNII |
CZ5312222S
|
| Synonyms |
Nicardipine | Cardene | Vasonase | Antagonil | Cardene SR | Dagan | Flusemide | Lecibral | Lincil | Loxen | Lucenfal | Nicardipine Hydrochloride | Hydrochloride, Nicardipine | Nicardipine LA | LA, Nicardipine | Nicardipino Ratiopharm | Perdipine | Ridene | Y-93 | Y 93 | Y93 | Cardene I.V. | Nicardipino Seid |
|
| Chemical Information |
| Molecular Formula |
C26H29N3O6 |
| CAS Registry Number |
55985-32-5 |
| SMILES |
CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
